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Background
Decades of research have helped mitigate numerous
sources of error in phase contrast MRI (PC-MRI), never-
theless chemical shift induced phase errors (CS errors)
and spatiotemporal undersampling errors (STU errors)
remain critical sources of error for which a cogent error
mitigation strategy is needed. CS errors, which arise in
PC-MRI because the complex signal for perivascular fat
chemically shifts across the vessel wall and corrupts the
complex blood signal, can be mitigated with an in-phase
TE (TEIN) and a high receiver bandwidth [1]. STU errors
arise from suboptimal spatiotemporal resolution. The
objective was to design a PC-MRI sequence with improved
sequence efficiency and evaluate the impact on mitigating
both CS and STU errors.
Methods
Hargreaves et al. [2] have shown that convex optimization
(CVX) can be used to minimize gradient waveform dura-
tions subject to both hardware constraints (maximum
available gradient amplitude and slew rate) and pulse
sequence constraints (e.g. VENC, RF pulse, slice thickness,
FOV, bandwidth, matrix size). We developed CVX PC-
MRI to achieve improved spatiotemporal resolution to
reduce STU errors while using the minimum TEIN (TEIN,
MIN) to reduce CS errors for a fixed breath hold duration.
Flow measurements were obtained at 3T (Siemens Trio)
using a conventional flow compensated and flow encoded
(FCFE) PC-MRI sequence and CVX PC-MRI optimized
for high spatial resolution (CVX-SR) or high temporal
resolution (CVX-TR). All sequences mitigated CS errors
with a high receiver bandwidth and TEIN. CVX permits
using TEIN,MIN = 2.46 ms while the FCFE sequence can
only achieve TEIN = 4.92 ms. Total flow and peak velocity
measurements were acquired in the ascending aorta (aAo),
main pulmonary artery (PA), and right/left pulmonary
arteries (RPA/LPA) of ten (N = 10) normal volunteers
(Table 1).
Results
The sequence efficiencies (readout duration/TR) were
17.7% for FCFE, 30.5% for CVX-SR, and 31.4% for
CVX-TR. Measurements of total flow and peak velocity
were significantly higher (P < 0.05) for CVX-SR and
CVX-TR compared to FCFE (Table 2). On average,
CVX-SR measured 8.1% higher total flow and 3.8%
higher peak velocity and CVX-TR measured 5.1% higher
total flow and 10.5% higher peak velocity.
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Table 1 PC-MRI parameters.
FCFE CVX-SR CVX-TR
TEIN/TR (ms) 4.92/7.00 2.46/4.00 2.46/3.95
Temporal resolution (ms) 55.9 56.1 31.6
VENC (cm/s) 150 150 150
Parallel acceleration rate-2 GRAPPA with 24 reference lines
Flip angle (degrees) 30 30 30
Segments 4 7 4
FOV (mm) 340 × 255 340 × 255 340 × 255
Pixel number 192 × 144 288 × 216 192 × 144
Pixel size (mm) 1.8 × 1.8 1.2 × 1.2 1.8 × 1.8
Bandwidth (Hz/px) 814 827 814
Duration (heart beats) 23 20 23
Acquired cardiac phases † 13-18 13-18 23-32
†The number of acquired cardiac phases is heart rate dependent
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Conclusions
CVX PC-MRI nearly doubles sequence efficiency,
reduces CS and STU errors, and produces more accurate
measurements of blood flow and peak velocity. CVX-SR
reports the highest total flow and CVX-TR reports the
highest peak velocities, but further improvements in spa-
tiotemporal resolution may still be needed for accurate
quantification.
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aAo 89.0 ± 18.2 95.9 ± 19.4† 93.5 ± 17.9†
PA 92.6 ± 18.5 100.1 ± 20.1† 97.2 ± 18.0†,‡
RPA 48.1 ± 9.5 52.5 ± 9.9† 50.9 ± 9.5†,‡
LPA 44.3 ± 8.7 47.7 ± 10.2† 46.4 ± 9.0†
Peak Velocity (cm/s)
aAo 117.2 ± 17.2 121.6 ± 15.3† 127.3 ± 15.8†,‡
PA 87.0 ± 11.8 90.0 ± 13.5† 95.4 ± 15.4†,‡
RPA 93.8 ± 15.9 97.1 ± 16.8† 104.7 ± 21.7†,‡
LPA 95.3 ± 18.0 99.7 ± 19.8† 107.2 ± 19.9†,‡
Data are expressed as mean ± standard deviation † P < 0.05 shows a
statistical significant difference compared to FCFE. ‡ P < 0.05 shows a
statistical significant difference compared to CVX-SR.
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